• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sotac Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 78648.0
  • ISIN : INE0O2D01012
122.85 6 (5.00%)
  • As on 03 Nov 2026 (EOD)

  • Today’s Low

    122.85

  • Today’s High

    122.85

  • Open

    122.85

  • Perv Close

    117.00

  • 52W Low

    86.00

  • 52W High

    139.65

Key Indicators

  • P/E(TTM)

    28.11

  • Mar.Cap (₹Cr.)

    135.75

  • Div & Yield %

    0.16

  • Book Value(₹)

    52.33

  • Debt-Equity Ratio

    5.00

  • AGM Date

    03-Nov-2026

  • EPS

    4.37

  • P/E Ratio

    28.11

Financials Ratios

  • Debt-Equity Ratio

    0.72

  • Mar.Cap (₹Cr.)

    135.75

  • RONW (%)

    11.06

  • ROCE (%)

    10.19

Score Board

  • Equity (₹ in Cr.)

    11.05

  • BV (₹)

    52.30

  • Sales( ₹ in Cr.)

    71.88

  • NP (in Cr.)

    4.83

  • NP Var(%)

    1.0

  • Div%

    2.0

  • CPS (₹)

    6.60

  • EPS (₹)

    4.40

  • Traded Value (₹ in Lakhs)

    135.75

  • 52 Week High

    139.65

  • 52 Week Low

    86.00

  • Price BSE

    0.0

  • Price NSE

    123.00

  • Market Capital( in Cr.)

    135.75

  • P/C Ratio

    18.50

  • P/E Ratio

    28.10

  • Price Vs.BV

    4.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 71.88 62.38 67.11 57.98 73.15 43.44
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 71.88 62.38 67.11 57.98 73.15 43.44
Other Income 2.10 2.38 1.32 0.24 0.21 0.35
Stock Adjustments 0.70 -3.16 -0.48 3.18 0.45 1.48
Total Income 74.68 61.60 67.95 61.40 73.81 45.27
EXPENDITURE :            
Raw Materials 50.40 40.77 44.72 43.25 56.43 35.55
Power and Fuel Cost 1.05 1.07 1.19 0.99 0.86 0.72
Employee Cost 1.80 0.93 1.46 2.01 2.13 2.14
Other Manufacturing Expenses 4.73 4.38 4.08 3.87 4.41 2.18
Selling and Administration Expenses 5.27 4.25 4.81 2.49 1.70 1.32
Miscellaneous Expenses 0.21 0.14 0.39 0.32 1.89 0.14
Employee Benefit Expenses 1.80 0.93 1.46 2.01 2.13 2.14
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 63.46 51.54 56.65 52.92 67.41 42.05
Operating Profit 11.23 10.06 11.29 8.49 6.39 3.21
Interest 1.80 1.17 1.02 0.90 0.58 0.61
Gross Profit 9.43 8.89 10.27 7.59 5.81 2.60
Depreciation 2.50 2.47 2.51 1.63 1.13 1.11
Profit Before Tax 6.93 6.42 7.76 5.96 4.68 1.49
Current Tax 2.03 1.71 2.09 1.68 1.43 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.02 -0.07 -0.08 -0.21 -0.03 0.00
Reported Net Profit 4.92 4.77 5.75 4.50 3.30 1.48
Extraordinary Items 0.09 0.00 -0.17 0.00 -1.28 0.00
Adjusted Net Profit 4.83 4.77 5.92 4.50 4.58 1.48
Adjustment below Net Profit 0.00 0.00 0.00 -5.79 -0.54 0.00
P & L Balance brought forward 13.85 9.08 3.33 4.63 2.34 0.85
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.11 0.00 0.00 0.00 0.46 0.00
P & L Balance carried down 18.66 13.85 9.08 3.33 4.63 2.34
Dividend 0.11 0.00 0.00 0.00 0.46 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 2.00 0.00 0.00 0.00 20.00 0.00
Dividend Per Share(Rs) 0.20 0.00 0.00 0.00 2.00 0.00
Earnings Per Share-Unit Curr 4.45 4.32 5.20 5.58 14.33 6.45
Earnings Per Share(Adj)-Unit Curr 4.45 4.32 5.20 - - -
Book Value 52.33 47.99 43.69 14.31 30.87 20.90
Book Value(Adj)-Unit Curr 52.33 47.99 43.69 - - -

Shareholding Pattern

  • Promoter Group

    72.85%

  • Public Share Holding

    27.15%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,050,000 72.85 8,050,000 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,050,000 72.85 8,050,000 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,819,200 16.46 1,819,200 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,819,200 16.46 1,819,200 4
2] Non Institution
Bodies Corporate 562,800 5.09 562,800 10
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 20,400 0.18 20,400 6
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 26,400 0.24 26,400 10
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 201,600 1.82 201,600 6
Individuals holding nominal share capital up to Rs. 1 lakh 369,600 3.34 369,600 183
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,180,800 10.69 1,180,800 215
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,050,000 100.00 11,050,000 230

Company Background

Sotac Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sotac Pharmaceuticals Ltd
  • BSE Code : 78648.0
  • ISIN : INE0O2D01012

  • Incorporation Year

    2015

  • Registered Office

    Plot No PF-21 Nr ACME Pharma
    Opp Teva Pharma Sanand GIDC-II, Ahmedabad,
    Gujarat-382110

  • Telephone

    91-90819 93300

  • FAX

  • Chairman

    Sharadkumar Dashrathbhai Patel

  • Managing Director

    Sharadkumar Dashrathbhai Patel

  • Company Secretary

    Niyati Dipesh Parikh

  • Auditor

    Keyur Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Sotac Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sotac Pharma. 122.85 73.98 71.88 27.61 12.19
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77